Huber K, Kirchheimer J, Binder B R
J Lab Clin Med. 1984 May;103(5):684-94.
Specific inhibiting IgG antibodies were raised in a rabbit using purified human high molecular weight urokinase as antigen. The antibodies reacted with both high molecular weight and low molecular weight human urokinase using an Ouchterlony double-immunodiffusion technique in such a way that one line of complete identity was obtained. Neither precipitation nor functional inhibition was observed for the tissue-type plasminogen activator. Kinetic studies with plasminogen as a natural high molecular weight substrate or the synthetic low molecular weight p-nitroanilide substrate pyro-Glu-Gly-Arg-pNA revealed, for both substrates, mainly a competitive type of inhibition for the Fab fragments of the specific anti-urokinase antibodies. This characterized anti-urokinase IgG was employed to develop a competitive radioimmunoassay, for human urokinase with 125I-labeled urokinase as tracer. In this radioimmunoassay, the lower detection limit for urokinase antigen was 10 pg/ml sample; the intrassay variation was 2.8%, and the interassay variation was 5.3%. Applying this radioimmunoassay to plasma samples obtained from healthy young volunteers, urokinase antigen could be measured in a concentration of 7.82 +/- 3.97 ng/ml for mean and 6.66 +/- 2.39 ng/ml for women (mean +/- SD).
以纯化的人高分子量尿激酶作为抗原,在兔体内产生了特异性抑制性IgG抗体。使用双向免疫扩散技术,这些抗体与高分子量和低分子量的人尿激酶都发生反应,从而得到一条完全相同的沉淀线。对组织型纤溶酶原激活剂未观察到沉淀或功能抑制现象。以纤溶酶原作为天然高分子量底物或合成的低分子量对硝基苯胺底物焦谷氨酸-甘氨酸-精氨酸-对硝基苯胺进行动力学研究,结果表明,对于这两种底物,特异性抗尿激酶抗体的Fab片段主要表现为竞争性抑制类型。利用这种特性化的抗尿激酶IgG,以125I标记的尿激酶作为示踪剂,开发了一种用于检测人尿激酶的竞争性放射免疫分析方法。在这种放射免疫分析中,尿激酶抗原的最低检测限为每毫升样品10皮克;批内变异为2.8%,批间变异为5.3%。将这种放射免疫分析方法应用于从健康年轻志愿者采集的血浆样品,测得尿激酶抗原浓度男性平均为7.82±3.97纳克/毫升,女性为6.66±2.39纳克/毫升(平均值±标准差)。